Leukemia Clinical Trials

Showing 2681-2700 of 10,987 trials

Bridging Generations: Educating Children on Dementia and Fall Prevention Through Animation

NCT07000370

A retrospective data review was conducted on a case-control trial involving 60 children (29 boys, 31 girls) as part of a public education initiative hosted on the web-based platform "Hand in Hand Across Barriers - Public Education Platform" (Facebook).

Fall Prevention in Healthy Aging

Northumbria University60 participantsStarted Sep 2021

Newcastle, United Kingdom

COMPLETED

A Study to Assess the Safety of Xospata in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-Like Tyrosine Kinase 3 (FLT3) Mutation

NCT04691648

The objective of this study is to describe the observed safety profile of Xospata® 40 mg tablet when administered in patients with relapsed or refractory AML with FLT3 mutation in routine clinical practice in Korea.

Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation

Astellas Pharma Korea, Inc.33 participantsStarted Jun 2022

Wŏnju, Gangwon-do, South Korea • Goyang-si, Gyeonggi-do, South Korea • Jeollanam-do, Hwasun-gun, South Korea +7 more locations

RECRUITINGPhase 1

Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies

NCT02203903

This Phase I dose-escalation trial is designed to evaluate the safety of administering rapidly -generated tumor multi-antigen associated -specific cytotoxic T lymphocytes, to HSCT recipients with high risk AML and MDS.

Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS

Catherine Bollard50 participantsStarted Jan 2015

Washington D.C., District of Columbia, United States • Baltimore, Maryland, United States

Bridging Generations: Educating Children on Dementia and Fall Prevention Through Animation

A Study to Assess the Safety of Xospata in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-Like Tyrosine Kinase 3 (FLT3) Mutation

Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies

Related Searches

MAGIC Ruxolitinib for aGVHD

A Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin® in Advanced Non-squamous Non-small Cell Lung Cancer Patients

The Swallowing Function of Oral Cancer Surgery

Neoadjuvant Durvalumab and Chemotherapy Followed by Surgery/CRT and Durvalumab in Borderline Resectable Stage III NSCLC

Prospective Randomized Controlled Trial of VR Cognitive Training in Reducing Postoperative Delirium in Elderly Patients With Cerebral Small Vessel Disease Undergoing Non-Cardiac Surgery

Robotic-Assisted System in Enhancing Balance, Postural Stability, Functional Gait and Fall Efficacy in Older Adults

Efficacy and Safety of ATO Plus ATRA in Nucleophosmin-1 Mutated Acute Myeloid Leukemia

Efficacy and Safety of Chidamide in CBF Leukemia

Urgent Panendoscopy in Patients Presenting With Hematochezia

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma

Gilteritinib in Combination With Venetoclax and Azacitidine for AML Patients With FLT3 Mutations Ineligible for Intensive Treatment

Use of Venetoclax , AML , Sohag , Egypt

Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors

Clinical Utility of Handheld Hydrogen Breathalyzer in Identification of Food Sensitivities (AIRE Study)

Can Education for Rural Women Lift the Fog Behind Closed Doors?

Effect of Virtual Reality and Serious Games on Pain, Fear, Anxiety, and Satisfaction During Skin Prick Testing in Children